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Saudi Journal of Ophthalmology (2012) 26, 235–239Case ReportDiffuse large B-cell lymphoma of the orbit: A tertiary eye care center
experience in Saudi ArabiaqHind M. Alkatan, MD ⇑; Ahmad M. Alaraj, MD; Ayman Al-Ayoubi, MDAbstractPrimary Diffuse Large B-cell Lymphoma (DLBCL) represents the 2nd most common lymphoma occurring in the orbit, after Mucosal
Associated Lymphoid Tissue (MALT) lymphoma. A total of 5 cases of ocular adnexal DLBCL were diagnosed over 25 years of expe-
rience at our tertiary eye care center. Two cases involved the lacrimal sac and one case involved the lacrimal gland. In this paper we
are presenting the remaining 2 non-lacrimal cases of DLBCL. The first case is a 32 year old male who was referred with a slowly
growing, painless mass involving the left medial canthal area as a case of dacryocystitis. The mass was found to be extending into
the orbit inferiorly with upward displacement of the left globe. The second case is a 65 year-old lady who presented with unilateral
proptosis as a result of a right orbital mass extending to the orbital apex. Histopathologic examination and immunohistochemical
analysis of the incisional biopsy in both cases confirmed the diagnosis of Diffuse Large B-cell Lymphoma (DLBCL).
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Lymphoproliferative disease of the orbit includes a wide
range of disorders including lymphoid hyperplasia and indo-
lent lymphomas. Primary Diffuse Large B-cell Lymphoma
(DLBCL) represents the 2nd most common lymphoma occur-
ring in the orbit, after Mucosal Associated Lymphoid Tissue
(MALT) lymphoma. The diagnosis requires careful clinical,
radiological, histopathological and immunohistochemical
examination.1
Five cases of ocular adnexal DLBCL cases were diagnosed
in our institution over a 25-year experience. Two cases
involved the lacrimal sac, one case involved the lacrimal
gland and the remaining last 2 cases showed different
non-lacrimal orbital involvement. We are reporting these 2
cases of DLBCL with an overall clinical, histopathologic and
radiologic data. Both cases presented initially with ophthal-
mic manifestations and no history of systemic lymphoma.Peer review under responsibility
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e-mail address: hkatan@kkesh.med.sa (H.M. Alkatan).The mass in the first case involved the inferior orbit with
no proptosis but visible extension to left lacrimal sac area
and the case was referred as dacryocystitis. The second case
presented with a typical right orbital mass resulting in unilat-
eral proptosis. The systemic work up in the first case was
completely negative, thus this lesion was considered
primary. Work up of the second case revealed mediastinal
lymphadenopathy indicating a possible secondary orbital
involvement.Case 1
A 32 year old male was referred by a general ophthalmol-
ogist as a non-urgent case of left chronic dacryocystitis. The
patient gave a history of tearing and a slowly growing, pain-
less swelling just near the left medial canthal area for several
months. There was no history of trauma, blood transfusion orj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
September 2011; available online 28 December 2011.
Hospital, P.O. Box 7191, Riyadh 11462, Saudi Arabia
Figure 1a. The clinical appearance of the left medial canthal area
swelling in case 1.
Figure 1c. Axial T2 weighed magnetic resonance image of the left orbital
lesion. Note the globe indentation by the mass (red arrow).
Figure 1d. The clinical appearance of the same patient showing resolved
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other systemic symptoms. Past medical and drug history
were not significant. Family history was also unremarkable.
On examination, the best corrected visual acuity was 20/
20 in both the eyes. The intraocular pressure (IOP) was
16 mmHg in each eye. Examination of the right eye was with-
in normal limit. External examination of the left eye revealed
fullness of left lower lid involving the medial canthal area. A
palpable tender firm mass was felt extending from the medial
canthus to the anterior part of the orbit just inferior to the left
globe (Fig. 1a). The globe was displaced upward with no evi-
dence of proptosis. Regurgitation from upper and lower
puncta was negative. Ocular motility was full. The remaining
ocular examination was within normal limits. His systemic
examination revealed no abnormality.
A Computerized Tomography (CT) scan of the left orbit
showed a mass with intermediate attenuation measuring
2.9  2.8 cm in the left inner canthus region in close proxim-
ity to the lacrimal sac (Fig. 1b). Magnetic Resonance Imaging
(MRI) of the left orbit showed a soft tissue mass of intermedi-
ate signal intensity on T1 and T2 weighted images in the area
of the left lacrimal sac with intra-orbital, extra-conalFigure 1b. Computerized tomography (Axial) of the left orbit with
contrast enhancing mass medially (red arrow).
swelling following treatment.component, all measuring 3  1.8 cm (Fig. 1c). The globe
was pushed laterally with abnormal contour of its wall medi-
ally. The mass showed mild homogenous contrast enhance-
ment except for a non-enhancing center.
The patient underwent debulking of the lesion through a
lower eyelid incision. The mass was found intra-operatively
to be separate from the lacrimal sac. The Histopathologic
examination revealed diffuse proliferation of sheets of large
lymphocytes with frequent mitotic figures. The cells showed
evidence of pleomorphism with vesicular nuclei and promi-
nent nucleoli (Fig. 2a). The immunohistochemical staining
showed that the cells were CD20, Bcl2 and Ki-67 positive
(Figs. 2b,c,d) while negative to CD10. The differential histo-
pathologic diagnosis based on the morphology included Dif-
fuse Large B-Cell Lymphoma (DLBCL) and Burkitt lymphoma,
however the immunohistochemical staining (specifically the
strong positivity to CD 20 and the negative CD10) supported
the diagnosis of DLBCL. The specimen was also submitted for
FISH analysis for c-myc translocation, which was negative,
thus ruling out the diagnosis of Burkitt lymphoma.
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count; CT scan of the head, neck, chest and abdomen; bone
marrow aspirate and biopsy – did not reveal any evidence of
systemic lymphoma. Thus, this was considered as primary
orbital lesion and staged as 1-A. The patient received 3
courses of R-CHOP chemotherapy as a preferred therapy.
He tolerated the chemotherapy with good response and no
complication (Fig. 1d). The patient is on regular follow-up
without evidence of local recurrence or advanced disease
up to 15 months after his treatment.igure 2c. Similar positive staining with Bcl2 (original magnification
400).Case 2
A 65-year old Saudi lady presented with the history of
painless progressive proptosis of her right eye over
3 months. There was no history of trauma or significant med-
ical illness. The patient however, noticed weight loss over the
last few months. Examination of the right eye showed visual
acuity of 20/40 with pinhole with normal anterior segment
findings and intraocular pressure of 17 mmHg. External
examination revealed 4 mm of right proptosis (by Hertel
Exophthalmometer at base 94). Her extraocular motility was
full and there was no diplopia in any gaze. Her systemic work
up revealed mild anemia.Figure 2a. Histopathologic appearance of the diffuse large lymphocytes
infiltrating the muscle in case 1, (original magnification 400, hematoxylin
and eosin).
Figure 2b. Positive staining of these lymphocytes with CD20 stain
(original magnification 200).F
Figure 2d. Strong positive staining of the cells with Ki67 (original
magnification 200).Her MRI showed a right orbital heterogenous mass
measuring 2.5  2 cm with low signal intensity on T1 and
T2-weighted images. The mass was located between the
lateral and inferior recti extending along the lateral orbital
wall without extension into the optic canal. There was no
globe indentation. The mass showed ring contrast enhance-
ment (Fig. 3a).Figure 3a. Axial T1 weighed magnetic resonance image of the right
orbital mass with the ring of contrast enhancement in the second case
(red arrow).
Figure 3b. Diffuse large lymphocytes in the histopathologic sections of
the lesion in case 2. Note the infiltration of the orbital fat (original
magnification 200, hematoxylin and eosin).
Figure 3c. Almost all the cells show positive staining with CD20 (original
magnification 200).
Figure 3d. Focal positivity with CD3 (original magnification 200).
238 H.M. Alkatan et al.Incisional biopsy of the mass through lateral orbitotomy
was performed. The histopathologic examination showed
diffuse sheets of large cells with irregular nuclear membrane
and prominent nuclei. Numerous mitotic figures and inter-
vening apoptotic cells were also noted. In focal areas, small
mature lymphocytes were also observed. The cells infiltrated
the orbital fat (Fig. 3b). The cells showed strong positive
staining with CD20 (Fig. 3c). Scattered lymphocytes showed
positive staining with CD3 (Fig. 3d). Full systemic work upwas performed and her final diagnosis was DLBCL possibly
secondary in the orbit with mediastinal lymphadenopathy.
She was referred for systemic treatment and was started on
R-CHOP cycles with no further available follow-up.
Discussion
Lymphoma is the most frequent malignant tumor in the
orbit. It accounts for 11% of all orbital tumors and 55% of
malignant tumor.2
Orbital lymphomas are usually primary, however they are
rare. Only about 5% of the patients with disseminated non-
Hodgkin lymphoma (NHL) have secondary orbital
involvement.3
Primary lymphoproliferative disease of the orbit is a heter-
ogeneous condition, representing a spectrum of disease
from lymphoid hyperplasia, through indolent lymphomas,
such as Extranodal Marginal Zone Lymphoma (EMZL) and fol-
licular lymphoma, to more malignant types, such as diffuse
large B-cell lymphoma (DLBCL) and mantle cell lymphoma.1
Primary orbital and periorbital DLBCL is an uncommon
form of NHL. DLBCL represents the 2nd most common lym-
phoma occurring in the orbit, after Mucosal Associated Lym-
phoid Tissue (MALT) lymphoma.1,2,4 In our institution, only 5
cases were diagnosed over a 25-year period of ophthalmic
clinical practice.
Orbital lymphoma presents clinically as a painless, slowly
progressive, unilateral or bilateral mass with a median age
of presentation after the 5th decade and a mean age of
60 years at the time of diagnosis. The most frequent clinical
presentation includes palpebral or orbital mass and exoph-
thalmos.2 Our second case presented with proptosis at the
age of 65 years. The interval between the onset of symptoms
and diagnosis of orbital lymphomas was 1–2 months in the
cases reported by Rey-Porca.2 Our first case is unique be-
cause of earlier presentation in the 3rd decade of life and rel-
atively longer interval of proper diagnosis (7 months) due to
the location of the lymphoma which has led to the initial mis-
diagnosis of chronic dacryocystitis. Nirupma reported a sim-
ilar case in a young adult with painful progressive proptosis.3
S Morley reported 2 cases of orbital plasmablastic lym-
phoma (PBL) as a new entity of large cell lymphoma of the or-
bit which is more rapidly progressive and is associated with
wider local disease at presentation. It was suggested in the
report that painful proptosis and periocular sensory loss in
PBL can possibly be used to differentiate this entity from
DLBCL.5 T-cell/histiocyte-rich large B-cell lymphoma is an
uncommon variant of DLBCL which has been recently de-
scribed as a primary orbital lymphoma in a 37 year old male.6
Radiotherapy alone has been commonly used as a treat-
ment modality of ocular adnexal lymphoma, however sys-
temic chemotherapy is favored for orbital/periorbital
DLBCL.7 Localized ocular adnexal DLBCL, treated using mod-
ern chemotherapy/immunotherapy is generally associated
with a good prognosis.1 We have observed a good outcome
and disease-free follow-up period of 15 months in our first
case.
In conclusion, orbital DLBCL seems to be rare with only
few cases encountered in our institution. Further detailed
study on the occurrence of ocular adnexal lymphoprolifera-
tive disorders in our area is essential. It is important for gen-
eral ophthalmologist to be familiar with this type of
periocular pathology in order to avoid delays in the proper
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potentially a curable disease.
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